Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after...

Area of Science:

• Hematology
• Stem Cell Biology
• Oncology

Background:

• Post-graft hematopoiesis often shows long-term quantitative deficiencies in marrow progenitor cells.
• Autologous bone marrow transplantation (ABMT) is a common treatment for non-Hodgkin's lymphoma.

Purpose of the Study:

• To evaluate the functional capacity and proliferative potential of marrow CD34(+) cells post-ABMT.
• To compare progenitor cell function in patients before and after ABMT with healthy controls.

Main Methods:

• CD34(+) cells were isolated from 10 post-ABMT patients, 10 pre-ABMT patients, and 10 controls.
• Cells were cultured for 7 days with growth factors (stem cell factor, IL-3, IL-1beta).
• Clonogenic efficiency and expansion yields of progenitor cells (CFU-GM, BFU-E) were assessed.

Main Results:

• Post-ABMT patients showed decreased clonogenic efficiency for BFU-E compared to controls.
• Expansion yields of total progenitor cells were significantly lower in post-ABMT patients (147%) versus pre-ABMT (255%) and controls (246%).
• Deficiency was pronounced for BFU-E expansion in post-ABMT patients (61%) compared to pre-ABMT (220%) and controls (349%).

Conclusions:

• Marrow CD34(+) cells exhibit impaired proliferative potential months after ABMT.
• The impairment primarily affects erythroid progenitor cells and/or their commitment from immature stages.
• These findings suggest a functional deficit in hematopoietic recovery following ABMT.